retatrutide triple agonist glp-1 gip glucagon receptor Retatrutide, a GIP, and agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA Retatrutide: How the Triple Agonist

Most patients start feeling the appetite-suppressing effects of a GLP-1 within the first few weeks of treatment, with measurable weight loss building over the following months

Testosterone Recovery Obesity is one of the strongest suppressors of testosterone production in men

This article contextualizes the immediate impact on F&B consumption and highlights which opportunity areas to watch as the phenomenon continues to unfold

Gasnier, S

Berberine Extract Berberine is a plant compound that has a history of use in traditional medicine

As a result, researchers began exploring whether other molecules could produce similar multi-receptor signaling